MOH — authorised 21 May 2002
- Marketing authorisation holder: UNITED THERAP
- Status: likely_approved
MOH authorised Remodulin on 21 May 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 21 May 2002.
UNITED THERAP holds the Israeli marketing authorisation.